Number of Participants Who Had Reactogenicity Events (REs) 0-42 days after study vaccination [clinicaltrials_resource:1713aaa516449c861427468b96ca49a1]
Reactogenicity events (REs) are predefined solicited adverse events (AEs) that can potentially occur after vaccine administration. For the participants enrolled in this study REs include fever, runny nose/nasal congestion, sore throat, cough, vomiting, headache, muscle aches, chills, tiredness, and irritability.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of Participants Who Had Reactogenicity Events (REs) 0-42 days after study vaccination [clinicaltrials_resource:1713aaa516449c861427468b96ca49a1]
Reactogenicity events (REs) are predefined solicited adverse events (AEs) that can potentially occur after vaccine administration. For the participants enrolled in this study REs include fever, runny nose/nasal congestion, sore throat, cough, vomiting, headache, muscle aches, chills, tiredness, and irritability.
Bio2RDF identifier
1713aaa516449c861427468b96ca49a1
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:1713aaa516449c861427468b96ca49a1
measure [clinicaltrials_vocabulary:measure]
Number of Participants Who Had Reactogenicity Events (REs)
time frame [clinicaltrials_vocabulary:time-frame]
0-42 days after study vaccination
description
Reactogenicity events (REs) ar ...... , tiredness, and irritability.
identifier
clinicaltrials_resource:1713aaa516449c861427468b96ca49a1
title
Number of Participants Who Had ...... 2 days after study vaccination
@en
type
label
Number of Participants Who Had ...... 3aaa516449c861427468b96ca49a1]
@en